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A B S T R A C T
Thyroid hormones (THs) L-thyroxine and L-triiodothyronine, primarily known as metabolism regulators,
are tyrosine-derived hormones produced by the thyroid gland. They play an essential role in normal
central nervous system development and physiological function. By binding to nuclear receptors and
modulating gene expression, THs inﬂuence neuronal migration, differentiation, myelination, synapto-
genesis and neurogenesis in developing and adult brains. Any uncorrected THs supply deﬁciency in early
life may result in irreversible neurological and motor deﬁcits. The development and function of
GABAergic neurons as well as glutamatergic transmission are also affected by THs. Though the
underlying molecular mechanisms still remain unknown, the effects of THs on inhibitory and excitatory
neurons may affect brain seizure activity. The enduring predisposition of the brain to generate epileptic
seizures leads to a complex chronic brain disorder known as epilepsy. Pathologically, epilepsy may be
accompanied by mitochondrial dysfunction, oxidative stress and eventually dysregulation of excitatory
glutamatergic and inhibitory GABAergic neurotransmission. Based on the latest evidence on the
association between THs and epilepsy, we hypothesize that THs abnormalities may contribute to the
pathogenesis of epilepsy. We also review gender differences and the presumed underlying mechanisms
through which TH abnormalities may affect epilepsy here.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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The thyroid hormones (THs), triiodothyronine (T3) and its
prohormonethyroxine (T4) are important regulators of gene
expression. Through interaction with thyroid hormone receptors
(TRs), THs regulate cell development, homeostasis, differentiation,
growth and metabolism [1]. Thyroid hormones act in the
brain where they play an essential role in fetal and post-natal
brain development as well as the maintenance of adult brain
function [2]. The importance of THs in the central nervous system
(CNS) function is well conﬁrmed in both neonatal and adult* Corresponding author at: Neuroscience Research Center, Shahid Beheshti
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights rehypothyroidism [reviewed in [3]]. In addition, THs promotes CNS
repair, as it has been demonstrated that CNS re-myelination is
dependent on these hormones [4]. In addition, THs have non-
genomic and genomic effects on mitochondrial biogenesis and
function [5] and decreased activity of THs in humans is linked to
impaired mitochondrial biogenesis and function [6]. Furthermore,
THs abnormalities including both hypothyroidism and hyperthy-
roidism, have been shown to induce the production of reactive
oxygen species (ROS) and affect the oxidative capacity of the
adult brain by modulating antioxidant enzymes [7]. THs also
speciﬁcally modulate the development and function of GABAergic
interneurons in vitro and in vivo [8,9].
Epilepsy is one of the most common chronic neurological
disorders affecting people of all ages [10]. It is a disorder of
recurrent and spontaneous seizures resulting clinically into
permanent alterations of normal function and morphology of
neuronal cells and even cell death [11,12]. Though the actual
pathogenesis of epilepsy remains unclear, accumulating evidences
indicate that mitochondrial dysfunction [13], oxidative stress [11]served.
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inhibitory (GABA) amino acids in the brain [14], are among
important factors modulating its pathogenesis and seizure
generation.
Knowing that mitochondrial dysfunction, oxidative stress and
GABAergic deregulation are among the main characteristic of
epilepsy and the fact that these abnormalities are associated with
THs deﬁcits, all strengthen the viewpoint that THs might affect
epilepsy pathogenesis. The present review therefore provides an
overview of recent developments in the ﬁeld of THs function and
its possible role in the pathogenesis of epilepsy, as a chronic
neurological disorder.
2. Thyroid hormones
The thyroid hormones, T3 and T4, are two tyrosine-based
hormones that are synthesized by the thyroid gland. The release of
TH is controlled by the hypothalamic–pituitary–thyroid axis
(HPTA). The hypothalamus releases thyrotropin-releasing hor-
mone (TRH) which stimulates the pituitary gland to release thyroid
stimulating hormone (TSH). TSH binds to its receptor on the
thyroid gland and activates the synthesis and release of THs. The
majority of THs released by the thyroid gland is T4 which is then
enzymatically deiodinated to a more potent from, T3 [15]. Al-
though, THs exerts some non-genomic effects by binding to a
number of intracellular targets, as well as membrane receptor on
integrinaVb3 [16], these hormones mediate their main biological
functions primarily at the genomic level. The genomic effects of
THs are mediated by a subgroup of the nuclear hormone receptor
(NR) family of the ligand activated transcription factors. In order to
interact with TRs, THs must enter the cellular nucleus and bind to
TRs that are already bound to regulatory regions of the target
genes. To our knowledge, two major isoforms of TRs namely TRa
and TRb, have been characterized which are encoded by separate
genes (on human chromosomes 17 and 3). Alternative splicing of
these genes, gives rise to additional heterogeneity for each
member of the TRs (TRa-1 and c-erbAa-2 and TRb-1 and TRb-
2) [reviewed in [17]]. In contrast to the nuclear effects, the extra
nuclear effects, not dependent on nuclear receptors could occur
within a short period of time and may be facilitated by signal-
transducing pathways such as protein kinases and cyclic adenosine
monophosphate (cAMP) [18,19].
2.1. Thyroid hormone in CNS
As previously mentioned, CNS is one of target tissues for THs
where these hormones play an essential role in prenatal and
postnatal brain development as well as the maintenance of its
physiological function. Generally, the concentration of THs in the
CNS is much less than in the serum. This difference is caused by the
difﬁculty of transporting THs across the blood brain barrier (BBB).
Two main pathways have been proposed by which THs crosses the
BBB into the CNS. In the ﬁrst pathway, THs crosses the BBB through
OAT1P1C transporters and enter astrocytes end feet where T4 is
converted to T3, via the enzyme deiodinase 2. In the second
pathway, MCT8 transporters help THs to enter the CNS. THs can
also directly enter the brain via gaps in the BBB, where the
astrocytes end feet do not completely cover the capillaries
[reviewed in [3]]. Like the periphery, the central effects of THs
are primarily triggered by binding to TRs and then repressing or
activating the target genes [20].
2.2. Functions of thyroid hormones in CNS
The biological functions of T4 and T3 in the CNS have been
widely reported. Some reports show that T4 exerts onlynongenomic effects in the brain while T3 serves as a unique
agonist for nuclear TRs. However, others show that TR-a1 acts as a
sensor for both T3 and T4 while TR-b1 is more responsive to T3.
Therefore, it seems that the transcription response mediated
primarily by TR-a1 might be triggered by both T3 and T4 and more
pure T3 effects are mediated by TR-b1 [3].
One of the best-known functions of THs in the CNS is their role
in CNS development. It has been shown that gestational/neonatal
hypothyroidism changes cell migration pattern and decreases cell
number, synaptogenesis and dendritic arborization, as well as
axonal myelination. These developmental defects induced by
severe THs depletion are demonstrated in the cerebellum,
neocortex and hippocampus, and in heavily myelinated white
matter tracts, such as the corpus callosum [21]. It has been
consistently shown that THs deﬁciency during brain development
(congenital hypothyroidism) can lead to irreversible and progres-
sive intellectual deterioration (cretinism) and neurological deﬁcits.
Most of these defects could be prevented by timely diagnosis and
THs replacement therapy [22,23]. In addition to the early stages of
life, appropriate THs signaling also plays an essential role in adult
brain functions. The importance of THs in the function of adult
brain is well demonstrated in adult hypothyroidism which affects
the hippocampus and cortex and results in mood and behavior
abnormalities like anxiety, and depression-like symptoms, as well
as memory impairment [24,25]. Adult-onset hypothyroidism
reduces the number of newborn neuroblasts in the dentate gyrus.
THs deﬁciency impairs adult neurogenesis particularly in the
hippocampus, reduces hippocampus volume and contributes to
cognitive problems in hypothyroidism [25,26]. In addition, it has
been revealed that hypothyroidism is also associated with other
complications such as impaired myelination, delayed development
of the dendritic tree, reduced glial cells and axo-dendritic synapses
[27,28].
3. Epilepsy and its pathological features
The most characteristic feature of epilepsy is a continuous rise
in neuronal excitability which leads to an unduly sustained and
synchronous discharge of a group of neurons. In about half of
epileptic patients, no causative factors have been found yet while
in the other half, different causative factors such as oxygen
deprivation, trauma, infection, tumors and metabolic imbalances
are suggested to be involved in abnormal cellular discharges
[29]. Malfunctions of cerebral cortex development also participate
in the pathogenesis of epilepsy [30]. It has consistently been
proposed that macro or microscopic cortical abnormalities that
may occur in the ﬁrst or second trimester of pregnancy could lead
to epileptic seizures [31]. Non-neuronal cells of the CNS such as
microglia and astrocytes play a pivotal role in the maintenance of
tissue homeostasis and neuronal activity. Therefore, it is believed
that dysfunction of these cells may also participate in the
pathogenesis of epilepsy [32].
Considering the essential role of THs in early fetal brain
development and the profound effects of THs abnormalities on
brain neuronal cytoarchitecture, neurotransmitters and pro/
antioxidant systems [33], it would be conceivable to hypothesize
that THs dysregulation might play a determining role in the
pathogenesis of epilepsy. In the other sections of this review, THs
and their dysregulation, as well as how they may participate in the
pathophysiology of epilepsy have been discussed.
4. Thyroid hormones, adult CNS and epilepsy
Head injury is one of the causative factors of adult epilepsy and
on the other hand, patients with brain injuries have been shown to
have lower levels of THs. In patients with traumatic brain injury
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active form T3 catalyzed by deiodinase enzyme becomes impaired.
Furthermore, in the early phases of brain injury, TSH level is
decreased and this might be another causative factor for THs
decreased levels [reviewed in [34]]. In this regard, Crupiet al.
investigated the effect of T3 on a murine model of TBI and reported
that treatment of mice with T3 (1.2 mg/100 g body weight, i.p) one
hour after TBI can signiﬁcantly protect against brain trauma and
improve motor and cognitive function [35]. Though the repair
capabilities of the spinal cord and brain are limited, THs exert
regenerative effects on nerves cells. The myelination process was
also shown to be dependent on THs function in both peripheral and
central nervous systems [4]. THs are able to induce oligoden-
drocytes formation from multipotent neural stem cells and also
play a role in regulating different developmental stages of
oligodendrocytes [36,37]. However, the potential protective effects
of THs in post-TBI seizure events still remain unknown.
In addition, it has been shown that thyroid deﬁciency during
pregnancy and lactation make offsprings more susceptible to
audiogenic convulsion [38]. Persistently, it has also been reported
that mice lacking TRb are more susceptible to audiogenic seizures
[39]. Among the genes affected by THs, neurotrophic factors are of
special signiﬁcance, as they play a key role in pathophysiological
conditions such as seizures [40]. Neurotrophic factors exert a
variety of effects on neural differentiation, survival and growth,
and also inﬂuence neurotransmitter synthesis, synaptic plasticity
and neural excitability [41]. Neurotrophic factors that are shown to
inﬂuence epileptic conditions and seizures include ﬁbroblast
growth factor-2 (FGF-2), brain derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3), nerve growth factor (NGF), glial cell line
derived neurotrophic factor (GDNF), and the vascular endothelialFig. 1. Schematic representation of how THs regulate mitochondrial function (biogenesis,
genome (direct and indirect pathways).growth factor (VEGF) [42]. While some studies imply that
increased expression of many neurotrophic factors after brain
injury or acute seizures contribute to the neuroprotection of the
injured brain [43], some others proposed that some of these
neurotrophic factors such as BDNF and NGF, actually promote
epileptogenic changes [44]. It is well known that epileptogenic
insults increase the synthesis of BDNF and activation of trkB
receptors [45]. Subsequently, studies in animal models of epilepsy
show an increase of BDNF levels in surviving hippocampal cells
after glutamate receptor activation, at early post seizure delay
[46,47]. Though the precise role of neurotropic factors in post
seizure phase is not well deﬁned, the potential protective effects of
THs through modulation of neurotrophic factors or other genes
expression on seizure-induced neural damage needs to be studied.
5. Thyroid hormones and pathogenesis of epilepsy/
epileptogenesis
5.1. Thyroid hormones and mitochondria
Several lines of evidence showing that oxidative stress, free
radicals and mitochondrial dysfunction play important roles in
seizure generation and epileptogenesis are available [13,48,49]. On
the other hand, THs have non-genomic and genomic effects on
mitochondrial biogenesis and function [5]. Accordingly, THs are
shown to regulate the expression of target genes and eventually
mitochondrial biogenesis through three different pathways
(Fig. 1). In the ﬁrst pathway, T3 directly affects the mitochondria
through the binding of a mitochondrial localized receptor [50]. A
truncated product of the TRa gene named P43, located inside the
mitochondria provides binding sites for T3 in the mitochondrial oxygen consumption, and gene expression) affecting nuclear and/or mitochondrion
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response element (TRE)-like sequences on the mitochondrial
genome and triggers transcription in a ligand-dependent way in
the presence of TH [51]. Consequently, it has been reported that the
over-expression of P43 in vivo and in cell culture contexts
increases protein synthesis and mitochondrial transcription
[51]. In the second pathway, T3 attaches to nuclear-localized
TRs and TREs to control gene expression of nuclear-encoded
proteins that are destined to the mitochondria and in this way
affect mitochondrial biogenesis [50]. In the third pathway,
intermediary factors such as the peroxisome proliferator-activated
receptor gamma (PPARg), nuclear respiratory factor 1 (NRF-1),
NRF-2 transcription factors, as well as the peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC-1a) and
peroxisome proliferator-activated receptor gamma, coactivator
1 beta (PGC-1b) may be generated by THs and then these co-
activators enter the mitochondrion where they could regulate
another group of THs target genes [52]. Therefore, it seems that T3
can regulate mitochondrial gene transcription either via a direct
pathway through THs receptor actions or via an indirect pathway
which includes co-activators and intermediate factors.
As earlier mentioned, besides regulation of development and
growth, THs acts as a regulator of energy metabolism [53]. T3
strongly increases oxygen consumption and the rate of ATP
hydrolysis. Hyperthyroidism is associated with an increased rate of
oxygen consumption in most tissues except those from the testis,
spleen and adult brain [54,55]. It is believed that the proton leak
through the mitochondrial inner membrane is a key target for THs-
induced oxygen consumption. This THs mediated increase in
proton permeability through the inner membrane is thought to be
achieved via different mechanisms. Firstly, THs alter the phospho-
lipid composition and ﬂuidity of the mitochondrial membrane
[56]. It has been reported that while reduction in rat THs decreases
respiratory rates, alpha-glycerophosphate dehydrogenase activity
and proton permeability, T3 replacement therapy restores these
parameters after 9–12 h [57]. Mitochondrial uncoupling proteins
(UCPs) are anion carrier proteins in the mitochondria which
dissociate oxidative phosphorylation from ATP synthesis; they are
therefore, also referred to as mitochondrial proton leak [58]. Sev-
eral lines of evidence are available showing that UCPs gene
expression is increased by T3 [59–61]. Therefore, T3-induced
elevation of UCPs expression is another mechanism by which T3
increases proton leak [62].
In addition, the decreased activity of THs has been shown to be
associated with diminished mitochondrial function and biogenesis
[6] and interestingly, in cell lines with mitochondrial DNA
(mtDNA) deﬁciencies, THs treatment restores mitochondrial
functions [63]. These hormonal effects on mitochondria have
been examined in different brain structures and has been reported
that mitochondria in the striatum and the cerebral cortex are
sensitive to thyroid hormone action [64]. Therefore, it seems that
by controlling mitochondrial gene expression, THs modulates
mitochondrial biogenesis and oxidative phosphorylation capacity
in certain areas of the brain such as the striatum and cerebral
cortex [65]. Consistently, it has been evidenced that hypothyroid-
ism during primary mammalian brain development is associated
with reduced expression of different mitochondrial genes, as well
as mitochondrial impairment. However, the receptor type (nuclear
or mitochondrial) and the exact mechanisms by which THs exerts
mitochondrial effects during development are still unclear [66].
Compelling proofs obtained from humans and experimental
seizure models show that mitochondrial dysfunction and the
resulting oxidative stress contributes to the pathogenesis of
chronic epilepsy [67,68]. It has been demonstrated that mitochon-
drial Complex I in the brain seizure foci decreases in patients
suffering from temporal-lobe epilepsy (TLE) [69,70]. It has alsobeen shown that hippocampal complex I activity decreased in an
experimental model of status epilepticus [69]. Impaired mito-
chondrial metabolism accompanied by deregulated glutamate–
glutamine–GABA cycling was also observed in neurons and
astrocytes of epileptogenic hippocampal formations [71,72]. Col-
lectively, considering the role of THs, particularly T3, in normal
mitochondrial functions and the role of mitochondrial dysfunction
in epileptic processes, it can be concluded that abnormalities in
THs function may participate in the pathogenesis of epilepsy,
however, more direct studies are needed to prove this hypothesis.
5.2. Thyroid hormones and oxidative stress
Oxidative stress is an imbalance between the production of
oxidant agents and antioxidant activity of defense systems
[73]. While the adult brain comprises only about 2% of the entire
body mass, it uses 20–35% of the total absorbed oxygen in the lung
and consumes about 25% of the body’s glucose [74]. Mitochondria
are the core cell organelle that uses oxygen to produce energy
[75]. However, 1–2% of the oxygen used by the mitochondria is
incomplete and leads to the production of superoxide radicals in
cells. In the presence of free iron and through classical Fenton
reaction, superoxide radicals have a high propensity to react with
hydrogen peroxide and generate hydroxyl radicals unless these
superoxide radicals are deactivated immediately. These hydroxyl
and superoxide radicals together with the non-radical oxygen
and hydrogen peroxide species are known as reactive oxygen
species (ROS), which attack different biomolecules such as
proteins, DNA and lipids and mediate the process known as
oxidative stress [76].
Previous studies have suggested that ROS might play an
essential role in the generation of epileptic seizures [77]. Unlike
nuclear DNA which has a histone mediated protection, mtDNA has
no such protection. On the other hand, mtDNA is located adjacent
to the electron transport chain as the main source of superoxide
radical production. Therefore, mtDNA is reportedly considered as
an assailable target for oxidative stress [78]. As mammalian
mtDNA is the encoding source for some pivotal polypeptides of the
oxidative phosphorylation system, any damage to mtDNA might
hamper the expression of these important polypeptides and
eventually cause mitochondrial oxidative phosphorylation deﬁ-
ciency [79].
It has been shown that THs dysregulation, either hyperthyroid-
ism or hypothyroidism, affects antioxidant/oxidant balance and
promote ROS generation [80]. In this regard, Das and Chainy have
compared oxidative stress and antioxidant defense parameters of
mitochondrial and post-mitochondrial fractions of rat cerebral
cortex in hypothyroid, euthyroid, and hyperthyroid states and
reported that the body’s thyroid state signiﬁcantly affects the
brain’s antioxidant defense status [7]. While hypothyroidism
increases protein carbonyl and lipid peroxidation products as
oxidative stress indices in the mitochondrial fraction of the brain,
replacement of T3 restores these parameters [76]. Hyperthyroid-
ism is also associated with increased oxidative stress and affects
mitochondria as the primary target of oxidative stress [81].
The brain’s poor antioxidant defense system and high amount
of poly-unsaturated fatty acids makes it more susceptible to
oxidative attacks compared to other tissues like the lungs and liver
[7]. Oxidative stress has been shown to be implicated in a variety of
acute conditions like cerebral ischemia and chronic neurological
conditions including epilepsy [14]. Evidences abound showing that
oxidative impairment of mtDNA and subsequent mitochondrial
dysfunction participates in epileptic seizures [13,82,83]. Collec-
tively, as both hypothyroidism and hyperthyroidism promote
oxidative stress and oxidative stress plays an essential role in the
pathogenesis of epilepsy, it would be conceivable to hypothesize
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down the development of epileptic seizures.
5.3. Thyroid hormones and GABAergic neurons
Several lines of evidence show that THs modulate the
development and function of GABAergic neurons [8,9]. An in vitro
study on fatal rat brain reports that developmental increase in the
activity of glutamic acid decarboxylase (GAD) as the main enzyme
in the conversion of glutamic acid to GABA could be increased by
T3 administration [84]. Experimental neonatal hypothyroidism
has also been shown to decrease the activity of this enzyme in rat
brain [85–87]. Beside this enzyme, activities of other enzymes that
participate in GABA metabolism such as GABA-transaminase
(GABA-T) and succinate semialdehyde dehydrogenase (SSDH)
are also affected by THs, and consequently disturbance in THs
affects GABA life cycle. While induction of hypothyroidism in
developing brain decreases the activity of GABA generating and
destroying enzymes, replacement of TH is shown to restore these
changes. It has been proposed that impairment in GABAergic inter-
neurons development may contribute to locomotor dysfunction
and anxiety induced by THs deﬁcits [88–91]. Effects of TH
deﬁciency on GABA show complexity in neonatal and adult life
as induction of neonatal hypothyroidism by 131I injection
decreases GABAergic function in neonatal developing rat brain
[92], but in contrast, 131I injection to adult rats to induce adult-
onset hypothyroidism impairs the exchange of glutamate, gluta-
mine and GABA between neuronal and glial compartments andFig. 2. Schematic representation of the possible interactions between the thyroid and GA
respectively. GABA, g-aminobutyric acid; TRH, thyrotropin releasing hormone; TSH, thincrease GABA concentration [93]. Results similar to those
reported in adult rats were also observed when adult-onset
hypothyroidism was induced by intraperitoneal carbimazole
[94]. This increase in GABA following adult-onset hypothyroidism
is consistent with reports showing that GAD activity increases in
the visual cortex following hypothyroidism [95]. Induction of
hyperthyroidism by intraperitoneal T4 injection is shown to
decrease GABA and increase glutamate levels in the thalamus and
hypothalamus [94]. In addition, an in vitro study on brain
synaptosomes revealed that low nanomolar concentrations of T3
could increase depolarization-induced GABA release through a
direct, non-genomic mechanism [96]. It is thought that this T3
induced GABA release is achieved via a direct non-genomic effect
of T3 which increases Ca2+ uptake by the synaptosomes [97]. Based
on the presented evidences, it can be summarized that THs
differentially regulate the GABAergic system. THs induce or
increase GABA function in developing brain, but oppose it in
matured brain. This linkage presents a new ﬁeld of research to
elucidate if the effects of THs on GABAergic systems contribute to
the pathogenesis of epilepsy.
Interestingly, researches have proved that GABA also modulates
thyroid system function [91]. Generally, GABA inhibits thyroid
function at all three levels of the hypothalamus, pituitary, and
thyroid axes (Fig. 2) [91]. Beside this bidirectional interplay between
GABA and THs, GABA also plays an important role in seizure
suppression as an inhibitory neurotransmitter. Thus, in contrast to
adult brain, it can be presumed that THs inhibits seizures by
increasing GABAergic system during brain development.BA systems in vertebrates. The + and  symbols indicate stimulation and inhibition,
yroid stimulating hormone; T3, triiodothyronine; T4, thyroxine.
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Different studies have found a set of genes whose products
might be affected by THs or inﬂuence its function. These set of
genes is also found to be affected in a variety of other situations
such as epileptic seizures. Here, an attempt was made to provide
a brief review on latest evidences about the genes associated with
THs which are also implicated in epileptic situations.
A group of factors that are inﬂuenced by THs and their
dysregulation could participate in epileptic conditions is neuro-
trophins and nerve growth factors. It has been demonstrated that
in seizures induced by amygdala kindling, expression of neuro-
trophins could be changed; on the other hand, THs has also been
shown to modulate the expression of these factors. Investigating
the expression of neurotrophins following the depletion of THs
has shown that while the expression of BDNF mRNA in the
hypothalamus and pituitary gland increased, the expression of
NGF and NT-3 mRNA did not change. In this study, amygdala-
kindled seizures decreased the expression levels of NT-3 mRNA in
granule cell layer of the dentate gyrus, which interestingly was
reversed by THs replacement [98].
In addition, a number of studies have been published showing
that gene expression of thyrotropin-releasing hormone (TRH) and
its receptor are affected by seizures suggesting that TRH might play
a role in the pathogenesis of epilepsy [99,100]. Neuropeptide Y
(NPY) is another factor that is closely associated with THs. On one
hand, NPY is shown to negatively modulate TSH/T4 concentration
[101] and on the other hand, it has been shown that seizure
induction alters the expression of NPY and different NPY receptor
subtypes [102,103].
Proteomic studies on cerebrospinal ﬂuid (CSF) obtained from
TLE patients have shown an increase in vitamin D-binding protein
(DBP), indicating that this protein might be involved in the
pathology of epilepsy [104]. This binding protein and its partner
vitamin-D are also shown to contribute to thyroid pathologies
like thyroid autoimmune diseases and thyroid tumorigenesis
[105,106]. Another set of genes that participate in the process of
epileptogenesis and are also affected by THs are some of the
immediate early genes (IEGs) like Homer1, early growth response
1 (egr1) and activity-regulated cytoskeleton-associated protein
(Arc). Prenatal propylthiouracil (PTU)-induced hypothyroidism
decreases the hippocampal and cortical expression of immediate
early genes and indicates their involvement in brain defects caused
by developmental hypothyroidism [107]. The immediate early
genes on the other hand are shown to be over-expressed in
different regions of the hippocampus and cortex of epileptic
animals and therefore may play a signiﬁcant role in seizure-
induced synaptic reorganization [108,109].
7. Thyroid hormones, gender differences, sex steroids, and
epilepsy
The role of sex hormones in the development of animals cannot
be overlooked, especially when it comes to development of the
brain and the central nervous system. It is well evident that sexual
differentiation of the brain leads to lasting changes in its structure
and function. This process to a great extent is under the inﬂuence of
sex and other circulating hormones, as well as the interaction of
the environment and the developing neurons; nutrients, medica-
tion and other chemical substances are also able to inﬂuence the
process [110].
Epidemiological studies have suggested that males have a
slightly higher incidence of epilepsy and unprovoked seizures
compared to females. Though it seems that males are at greater
risk than females for seizures and epilepsy, this is not appealable
for all types of epilepsies. For instance, idiopathic generalizedepilepsies (IGEs) have a higher prevalence in females [111]. Several
lines of evidence show that sex hormones, beside their roles in
brain development are also involved in the regulation of neuronal
excitability and survival. Fluctuations in sex hormones could affect
the pathogenesis of epilepsy and furthermore, seizures affect the
function of the sexual endocrine system (reviewed in [10]). As
mentioned earlier, THs are of special importance in the process of
brain development and therefore, it is conceivable to assume that
sex hormones and THs interact with each other during brain
development. Accordingly, it is reported that hypothyroidism
prolongs the critical period for the defeminization process induced
by testosterone; on the other hand, hyperthyroidism leads to
premature termination of testosterone sensitivity [112].
Like steroid hormones, THs, steroids interact with their
receptors to alter genomic activity and affect protein synthesis
during development and other stages of life. As is the case with T4,
the metabolic transformation of testosterone and progesterone is
critical for their actions. In addition, THs and sex steroid hormones
differentially alter brain functions in adults when compared to the
developmental stages [113–115]. Another important factor that
demonstrates the relation and interaction between steroids and
THs is the thyroid hormone receptor-associated protein
(TRAP220). TRAP220 is a coactivator for nuclear receptors, recruits
TRAP mediator complex to the hormone responsive promoter
regions and stimulates gene transcription. In other words,
TRAP220 enhances the function of TRs, steroid hormone receptors,
retinoic acid receptor a and vitamin D receptor [116,117]. De-
creased TRAP220 mRNA levels in epileptic tissue can be an
indicator of the role that TRAP220 plays in the neuropathology of
epileptic seizures [118]. In other studies, both the gene and protein
expression levels of TRAP220 in brains of epileptic patients were
measured. The focus was on the temporal lobes of patients with
chronic pharmaco-resistant epilepsy who underwent surgery. The
results showed that expression of TRAP220 mRNA in the temporal
cortex was signiﬁcantly reduced in epileptic patients both in
mRNA and protein levels. This decrease might affect the
pathophysiology of epilepsy and may be related to subsequent
brain damage after frequent seizures [119,120].
Another important factor involved in the interaction between
THs and steroids is the type 3 deiodinase or D3, which is necessary
for the maturation and function of the brain. D3 has distinctively
high expression in the brain of new born rats and usually occurs in
those areas of the rat brain which are involved in sexual
differentiation [113,121]. D3 Deﬁciency profoundly alters THs
availability before and after birth and increases its availability
during the perinatal period [122–124]. D3 protects the brain from
high doses of T3 by reducing its effects. D3 itself is also regulated
by the effect of thyroid hormones on the TRa1 receptor subtype
[125,126].
It has also been indicated that development of CNS and sex
hormones are important factors in the susceptibility of the brain to
seizures. Seizures in general and epileptic seizures in particular are
more likely to develop in the immature brain. Male infants and
newborns are more likely to experience epileptic seizures or
develop an unprovoked seizure than females. Sexual differences
which are expressed in the development of seizure-suppressing
neuronal networks can be considered as one of the reasons behind
this susceptibility [127]. These observed differences are mostly
linked to the type of epileptic disorder. For instance, gender
difference was identiﬁed in idiopathic generalized seizure in two
population-based studies; in an outpatient study, the differences
were attributed to gender differences in juvenile absence epilepsy
and juvenile myoclonic epilepsy [128,129]. As previously men-
tioned, females in general are at a greater risk of IGEs, which is
probably because of the effects of sex hormones. This assumption
is supported by the observation that IGE is more likely to occur in
S.M.S. Tamijani et al. / Seizure 31 (2015) 155–164 161females between the ages of 15 and 50 and before menopause
[111,130,131]. Among patients with cryptogenic localization-
related epilepsy, women were more frequent. Therefore, it seems
that non-symptomatic epilepsy more often occurs in women in
contrast to symptomatic localization-related epilepsy, which has
preponderance in men.
On the other hand, males may be more vulnerable to brain
damage induced seizure [132], and development of generalized
tonic–clonic seizures [133]. They are also more susceptible to
develop symptomatic localization-related epilepsy which can be
attributed to higher risk of physical damage to the brain and the
consequent seizures [128,134]. The differences between genders
are mostly expressed in ages 30–59; which is the age range for
higher TBI risks. Males are also more probable to experience brain
damages accompanied with seizures [135,136]. A gender depen-
dent difference has also been reported in childhood absence
epilepsy [137,138]. A quantitative analysis showed that there is a
sex difference in the number of spines and primary dendrites on
the apical CA3 pyramidal cells of the hippocampus. In this study,
females possessed more primary dendrites while males showed
more apical excrescences and interestingly, neonatal treatment
with thyroid hormone resulted in long-lasting and dramatic
changes in the entire CA3 pyramidal cells [139].
8. Antiepileptic drugs and thyroid hormones
Several lines of evidence show that antiepileptic drugs (AEDs)
affect different aspects of THs hemostasis such as biosynthesis,
release and transport as well as metabolism in both children and
adults [reviewed in [140]]. In this regard, in 1981 Strandjord et al.
reported for the ﬁrst time that treatment with some AEDs could
affect thyroid function [141]. In accordance, Yilmaz et al. have
evaluated the effects of widely used AEDs on thyroid function in
children with new onset and controlled epilepsy. They reported
that during a 12-months period of therapy, all AEDs except
levetiracetam increased TSH level and decreased fT4 concentration
[142]. In another study, it was reported that carbamazepine
monotherapy in epileptic children and adult patients impaired
thyroid function [143]. Evidences are also available showing that
AEDs affect the cellular mechanism of TH functions. For instance, a
single injection of diazepam (a benzodiazepine) after 24 h affects
nuclear T3 binding and relative expression of TH receptor TRa2 but
not TRa1 and TRb1 and synaptosomal TH availability [144]. Alter-
natively, THs also modulate in vivo and in vitro binding of
benzodiazepines on their speciﬁc membrane receptors
[145,146]. These results raise the risk of using AEDs in patients
with TH deregulation [147]. It must be emphasized that AEDs-
induced alteration in thyroid function is not permanent and could
be reversed by termination of their intake. For instance, it was
reported that the serum level of fT4 increased 4 months after
withdrawal of carbamazepine in epileptic men and women [148].
Interestingly, thyroid function is also sensitive to drugs used to
induce seizure in experimental models. In this regard, Bolaris et al.
investigated if central responses to THs are affected by a single
convulsion dose of pentylenetetrazole (PTZ). Their results showed
that 4 h after PTZ-induced seizures, the density of speciﬁc T3
nuclear receptors increased in the cerebral hemispheres while the
non T3 binding receptor (TRa2) decreased. These effects were
associated with an increased synaptosomal T3 level during
epileptic seizures [149].
9. Conclusion
Although the complete pathogenesis of epilepsy still remains
to be elucidated, it is well demonstrated that mitochondrial
dysfunction, oxidative stress and deregulation of GABAergicsystem play pivotal roles in this process. In spite of the fact that
BBB impedes the access of THs to the CNS and limits the
concentration of these hormones compared to that of serum,
researches have now shown that THs play essential roles in
different physiological aspects of the CNS such as development,
normal brain function and repairing machinery. Molecular
evidences have shown that THs participate in normal mitochon-
drial biogenesis and lack of their function causes mitochondrial
dysfunction and oxidative stress. In addition, it is well evidenced
that the development and function of GABAergic neurons depends
on normal THs function. A massive body of knowledge has been
gathered over the past decades to support the positive effects of
THs on neural cells regeneration. However, BDNF, one of the most
important neurotrophic factors inﬂuenced by THs, seems to cause
detrimental effects on the development and aftermaths of
epilepsy. Nevertheless, most collected evidence and knowledge
are in favor of the positive effect of THs and there is no doubt that
THs plays a signiﬁcantly inﬂuential role in various aspects of
epilepsy, from development to healing and recreation. However,
different theoretical ways by which THs is believed to contribute
to the pathologies of epilepsy should be further clariﬁed.
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